XML 119 R27.htm IDEA: XBRL DOCUMENT v2.4.1.9
Income Taxes
12 Months Ended
Dec. 31, 2014
Income Taxes [Abstract]  
Income Taxes

(18) Income Taxes

 

Income tax expense based on the Company’s income before income taxes consisted of the following for the years ended December 31, 2014,  2013, and 2012:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2014

 

2013

 

2012

 

 

(In thousands)

Current:

 

 

 

 

 

 

 

 

 

U.S. federal

 

$ 

19,033 

 

$  

26,766 

 

$  

503 

State and local

 

 

3,554 

 

 

5,503 

 

 

812 

Foreign

 

 

2,549 

 

 

1,216 

 

 

 —

Total current

 

$ 

25,136 

 

$  

33,485 

 

$  

1,315 

Deferred:

 

 

 

 

 

 

 

 

 

U.S. federal

 

$ 

1,639 

 

$  

11,648 

 

$  

24,005 

State and local

 

 

795 

 

 

(1,901)

 

 

1,749 

Foreign

 

 

604 

 

 

(1,214)

 

 

(60)

Total deferred

 

 

3,038 

 

 

8,533 

 

 

25,694 

Total income tax expense

 

$ 

28,174 

 

$  

42,018 

 

$  

27,009 

 

Income tax expense (benefit) differs from amounts computed by applying the U.S. federal statutory tax rate to income before taxes as follows for the years ended December 31, 2014,  2013, and 2012:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2014

 

2013

 

2012

 

 

(In thousands)

Income tax expense, at the statutory rate of 35.0%

 

$ 

22,179 

 

$  

21,932 

 

$  

24,595 

Provision to return and deferred tax adjustments

 

 

1,705 

 

 

(1,637)

 

 

200 

State tax, net of federal benefit

 

 

2,717 

 

 

2,275 

 

 

1,858 

Permanent adjustments

 

 

173 

 

 

(115)

 

 

322 

Foreign subsidiary tax rate differences

 

 

(985)

 

 

1,252 

 

 

120 

Impact of entity restructuring

 

   

 —

 

   

15,501 

 

 

 —

Other

 

 

338 

 

 

(6)

 

 

67 

Subtotal

 

 

26,127 

 

 

39,202 

 

 

27,162 

Change in valuation allowance

 

 

2,047 

 

 

2,816 

 

 

(153)

Total income tax expense

 

$ 

28,174 

 

$  

42,018 

 

$  

27,009 

 

Income tax expense for the year ended December 31, 2014 relates primarily to consolidated income generated from the Company’s U.S. operations.  The decrease in income tax expense, compared to the prior year, is primarily related to a $13.8 million charge recorded during the year ended December 31, 2013 related to deferred tax assets that were no longer realizable as a result of an internal restructuring in that period. 

 

The net current and noncurrent deferred tax assets and liabilities (by segment) as of December 31, 2014 and 2013 were as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

United States

 

Europe

 

Other International

 

 

2014

 

2013

 

2014

 

2013

 

2014

 

2013

 

 

(In thousands)

Current deferred tax asset

 

$

19,495 

 

$

17,652 

 

$

4,727 

 

$

3,576 

 

$

225 

 

$

171 

Valuation allowance

 

 

 —

 

 

 —

 

 

 —

 

 

(70)

 

 

(144)

 

 

(88)

Current deferred tax liability

 

 

 —

 

 

(2)

 

 

 —

 

 

(1,188)

 

 

 —

 

 

 —

Net current deferred tax asset

 

 

19,495 

 

 

17,650 

 

 

4,727 

 

 

2,318 

 

 

81 

 

 

83 

Noncurrent deferred tax asset

 

 

26,418 

 

 

31,414 

 

 

36,652 

 

 

24,487 

 

 

4,288 

 

 

3,945 

Valuation allowance

 

 

 —

 

 

 —

 

 

(10,989)

 

 

(9,900)

 

 

(2,591)

 

 

(2,008)

Noncurrent deferred tax liability

 

 

(39,653)

 

 

(36,264)

 

 

(17,717)

 

 

(5,909)

 

 

(1,838)

 

 

(1,755)

Net noncurrent deferred tax (liability) asset

 

 

(13,235)

 

 

(4,850)

 

 

7,946 

 

 

8,678 

 

 

(141)

 

 

182 

Net deferred tax asset (liability)

 

$

6,260 

 

$

12,800 

 

$

12,673 

 

$

10,996 

 

$

(60)

 

$

265 

 

The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities at December 31, 2014 and 2013 were as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2014

 

2013

 

 

(In thousands)

Current deferred tax assets:

 

 

 

 

 

 

Reserve for receivables

 

$

267 

 

$

258 

Accrued liabilities and inventory reserves

 

 

6,746 

 

 

5,069 

Net operating loss carryforward

 

 

4,566 

 

 

3,614 

Unrealized losses on interest rate swap contracts

 

 

11,365 

 

 

12,197 

Other

 

 

1,503 

 

 

261 

Subtotal

 

 

24,447 

 

 

21,399 

Valuation allowance

 

 

(144)

 

 

(158)

Current deferred tax assets

 

 

24,303 

 

 

21,241 

Noncurrent deferred tax assets:

 

 

 

 

 

 

Net operating loss carryforward

 

 

15,326 

 

 

17,350 

Unrealized loss on interest rate swap contracts

 

 

10,078 

 

 

13,548 

Stock-based compensation

 

 

8,057 

 

 

6,111 

Asset retirement obligations

 

 

2,757 

 

 

2,434 

Tangible and intangible assets

 

 

26,107 

 

 

15,970 

Deferred revenue

 

 

497 

 

 

798 

Other

 

 

4,536 

 

 

3,635 

Subtotal

 

 

67,358 

 

 

59,846 

Valuation allowance

 

 

(13,580)

 

 

(11,908)

Noncurrent deferred tax assets

 

 

53,778 

 

 

47,938 

Current deferred tax liabilities:

 

 

 

 

 

 

Other

 

 

 —

 

 

(1,190)

Current deferred tax liabilities

 

 

 —

 

 

(1,190)

Noncurrent deferred tax liabilities:

 

 

 

 

 

 

Tangible and intangible assets

 

 

(59,035)

 

 

(41,303)

Asset retirement obligations

 

 

(173)

 

 

(2,625)

Noncurrent deferred tax liabilities

 

 

(59,208)

 

 

(43,928)

 

 

 

 

 

 

 

Net deferred tax asset

 

$

18,873 

 

$

24,061 

 

We assess our deferred tax asset valuation allowances at the end of each reporting period. The determination of whether a valuation allowance for deferred tax assets is needed is subject to considerable judgment and requires an evaluation of all available positive and negative evidence. Based on the assessment at December 31, 2014, and the weight of all available evidence, we concluded that maintaining the deferred tax asset valuation allowance for certain of our entities in the U.K. and Mexico was appropriate, as we currently believe that it is more likely than not that these tax assets will not be realized. However, with increased recent profitability and increasing visibility into projected profitability in the U.K., we believe it is possible that the valuation allowance associated with certain U.K. entities could be reduced or removed in future periods.

 

The deferred tax benefits associated with the Company’s net unrealized losses on derivative instruments have been reflected within the Accumulated other comprehensive loss, net, balance in the accompanying Consolidated Balance Sheets.

 

As of December 31, 2014, the Company had approximately $8.3 million in U.S. federal net operating loss carryforwards that will begin expiring in 2021.    

 

As of December 31, 2014, the Company had approximately $66.7 million in net operating loss carryforwards in the U.K. not subject to expiration and $10.7 million in net operating loss carryforwards in Mexico that will begin expiring in 2016.  The deferred tax benefits associated with such carryforwards in Mexico and certain of the Company’s U.K. entities, to the extent they are not offset by deferred tax liabilities, have been fully reserved for through a valuation allowance.  

 

The Company currently believes that the unremitted earnings of its foreign subsidiaries will be reinvested in the corresponding country of origin for an indefinite period of time.  As of December 31, 2014, the unremitted earnings of these subsidiaries are not material.

 

The Company files U.S., state, and foreign income tax returns in jurisdictions with varying statutes of limitations. With few exceptions, the Company is not subject to income tax examination by tax authorities for years before 2011.